HealthEquity director to sell $804K in shares

A Rule 144 notice for HEALTHEQUITY, INC.

Rhea-AI Filing Summary

A Rule 144 notice for HEALTHEQUITY, INC. (HQY) states that director Adrian Dillon plans to sell 7,632 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 08/25/2026, with an indicated aggregate market value of $804,412.80. The shares are to be acquired by exercise of stock options for cash and sold on NASDAQ.

Key Figures

Shares to be sold: 7,632 shares of common stock Aggregate market value: $804,412.80 Planned sale date: 08/25/2026 +2 more

5 metrics

Shares to be sold 7,632 shares of common stock Planned sale by director Adrian Dillon under Rule 144

Aggregate market value $804,412.80 Value associated with 7,632 HQY common shares in the notice

Planned sale date 08/25/2026 Anticipated date for sale of 7,632 HQY shares

Acquisition method Exercise of Stock Options Method for acquiring the shares to be sold, from the issuer

Trading market NASDAQ Market on which the HQY common shares are to be sold

Key Terms

Rule 144, Exercise of Stock Options, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Stock Options financial

"Common | 08/25/2026 | Exercise of Stock Options | Issuer"

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 7632 | 804412.80"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale does this Rule 144 notice disclose for HQY?

The notice states that director Adrian Dillon plans to sell 7,632 shares of HEALTHEQUITY, INC. common stock pursuant to Rule 144.

What is the value of the HEALTHEQUITY, INC. (HQY) shares covered by this notice?

The Rule 144 notice indicates an aggregate market value of $804,412.80 for the 7,632 HEALTHEQUITY, INC. common shares referenced.

When are the HQY shares expected to be sold under this Rule 144 notice?

The notice lists an anticipated sale date of 08/25/2026 for the 7,632 HEALTHEQUITY, INC. common shares.

How will Adrian Dillon acquire the HQY shares to be sold?

The shares to be sold are to be acquired through an Exercise of Stock Options from the issuer, with the notice specifying payment in cash on 08/25/2026.

Which broker is handling the planned HQY Rule 144 sale?

The planned sale is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as the broker for the 7,632 HQY shares.

On which market are the HEALTHEQUITY, INC. (HQY) shares to be sold?

The Rule 144 notice specifies that the 7,632 HEALTHEQUITY, INC. common shares are to be sold on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 04:29 PM EDT Accepted by SEC EDGAR 08/25/2026 - 04:28 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001163402
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHEQUITY, INC.
SEC File Number	001-36568
Address of Issuer	15 West Scenic Pointe Drive, Suite 100 Draper UTAH 84020
Phone	8017271000
Name of Person for Whose Account the Securities are To Be Sold	ADRIAN DILLON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7632	804412.80	83602157	08/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2026	Exercise of Stock Options	Issuer			7632	08/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adrian Dillon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)